Norisoboldine
CAS No. 23599-69-1
Norisoboldine ( —— )
Catalog No. M18281 CAS No. 23599-69-1
Norisoboldine might be a potential therapeutic agent for rheumatoid arthritis, and it functions through protecting joint destruction as well as regulating the abnormal immune responses.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 54 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNorisoboldine
-
NoteResearch use only, not for human use.
-
Brief DescriptionNorisoboldine might be a potential therapeutic agent for rheumatoid arthritis, and it functions through protecting joint destruction as well as regulating the abnormal immune responses.
-
DescriptionNorisoboldine might be a potential therapeutic agent for rheumatoid arthritis, and it functions through protecting joint destruction as well as regulating the abnormal immune responses. Norisoboldine inhibits the macrophage activation and the resultant production of pro-inflammatory cytokines via down-regulating the activation of MAPKs signaling pathways rather than NF-κB.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorMAPK
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number23599-69-1
-
Formula Weight313.35
-
Molecular FormulaC18H19NO4
-
Purity98%
-
Solubility——
-
SMILESCOC1=C(C2=C3C(CC4=CC(=C(C=C42)OC)O)NCCC3=C1)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Bendamustine
Bendamustine for?the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
-
Sanguinarine
Sanguinarine is a specific inhibitor of Rac1b with anti-microbial, anti-oxidant and anti-inflammatory properties.
-
NSC622608
NSC622608 is a small-molecule ligand for V-domain Ig suppressor of T-cell activation (VISTA) which is an immune checkpoint that affects the ability of T-cells to attack tumors.